Modified polynucleotides for reducing off-target effects in RNA interference
Details for Australian Patent Application No. 2005230850 (hide)
International Classifications
Event Publications
23 November 2006 PCT application entered the National Phase
PCT publication WO2005/097992 Priority application(s): WO2005/097992
6 August 2009 Assignment before Grant
Dharmacon, Inc. The application has been assigned to Merck & Co., Inc.; Dharmacon, Inc.
17 September 2009 Application Accepted
Published as AU-B-2005230850
8 October 2009 Application for Amendment
The nature of the amendment is: Add co-inventor Linsley, Peter S. and delete co-inventor Fedorov, Yuriy. Address for service in Australia - Griffith Hack Level 3 509 St Kilda Road Melbourne VIC 3004
21 January 2010 Amendment Made
The nature of the amendment is: Add co-inventor Linsley, Peter S. and delete co-inventor Fedorov, Yuriy
28 January 2010 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005230851-Cetylpyridinium chloride as an antimicrobial agent in ophthalmic compositions
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser